Saturday, July 18, 2020

Has Canada’s stand on Israel-Palestine conflict cost it the UNSC Seat

This article is by

Share this article

Article Contributor(s)

Nikhita Gautam

Article Title

Has Canada’s stand on Israel-Palestine conflict cost it the UNSC Seat

Publisher

Global Views 360

Publication Date

July 18, 2020

URL

United Nations Security Council meeting

United Nations Security Council meeting | Source: Cancillería Argentina  via Wikimedia

On the 17th of June, 2020, Canada lost its bid for a temporary seat in the UN Security Council, the only UN body which can put binding resolutions on the member countries.. In the competition were Norway and Ireland, which won by 130 and 128 votes respectively where the votes required to secure a seat were 128. Canada, however, fell short by 20 votes.

It is a jolt to Canadian Prime Minister Justin Trudeau who had declared “Canada is back” to the world stage after the conservative government. He had personally campaigned for the seat but Canada received even fewer votes than what it received in 2010 under the conservative government of Stephen Harper. That is why Bessma Momani, a senior fellow at the Centre of International Governance and Innovation, calls it “embarrassing” and a “bit of a wake-up call.”

There have been many mixed reactions within Canada on the reason for the loss as well as the significance of this loss.

A professor at the Munk School of Global Affairs at U of T, Jance Stein, talks about how Canada in UNSC would have got trapped in the crossfire between US-Canada clashes. Andrew MacDougall, the ex-director of communications with the former PM Harper, says “UNSC hasn’t been relevant to global peace and security for more than 15 years”, implying that UNSC seat is not worth much.

There have been many reasons ascribed to the loss, the first and foremost being Canada’s staunch support of Israel. Canada has voted 116 times against UN resolutions for Palestinian rights, against Israel’s occupation, since 2000. It has also not opposed Israel’s planned annexation of the Jordan valley. “Just Peace Advocates” in association with over a hundred non-governmental organizations sent a signed letter to UN members countries, urging them to consider Canada’s votes against Palestinian refugees and illegal settlements while deciding on their votes for UNSC seat. It also pointed out how Canada considers Israel’s illegal territories as a part of it in trade, which is directly against UNSC Resolution 2334 which calls on member states to distinguish between Israel and its new territories occupied in 1967. As majority of the countries in UN show support for the Palestinian cause of a separate state and the well being of the war-wreckin Palestinian citizens, Canada’s unwavering support for Israel might have contributed to its defeat in winning UNSC seat.

Tamara Lorincz, a member of the Canadian Foreign Policy Institute pointed towards a more fundamental issue with Canadian foriegn policy management. He talked about how Canada hasn’t drafted a foreign policy to explain its stances on important global issues, hasn’t set aside enough funds for overseas development aid, has exported weapons to countries like Saudi Arabia, has snubbed negotiations on a treaty against nuclear weapons and many other shortcomings which make it undeserving of the seat.

This development, however, is beneficial for the Palestinians, since Canada would have supported Israel in the UNSC and opposed all such resolutions which may favour Palestinians and are critical to Israel. This loss may also force Canada to give a serious rethink to its Israel First policy. According to a poll by EKOS Research Associates, three in four Canadians want their government to oppose Israel’s annexation plans and 42% of them wanted sanctions against the country. There is also a campaign in Canada which calls on the Prime Minister “to fundamentally reassess Canadian foreign policy.”

It is too early to predict whether the loss of the UNSC seat will trigger some introspection in the foriegn policy circles of Canada or it will be business as usual.

Support us to bring the world closer

To keep our content accessible we don't charge anything from our readers and rely on donations to continue working. Your support is critical in keeping Global Views 360 independent and helps us to present a well-rounded world view on different international issues for you. Every contribution, however big or small, is valuable for us to keep on delivering in future as well.

Support Us

Share this article

Read More

February 4, 2021 5:14 PM

Asian countries & the race for COVID-19 Vaccine

Our relationship with the new strain of coronavirus is almost 8 months strong now. Countries like the US, Russia, UK, China, India, and many more have already set their brainy scientists in the task of developing a vaccine, turning it into a race which desperately needs a winner, since no one wants this deadly relationship to endure. Several attempts have proved to be successful, especially in countries like Russia, USA, India, and China.

China was the first to start scouring for a vaccine the day WHO declared that the new strain of SARS-CoV, originating in Wuhan-China, has resulted in a pandemic. It is a fierce competitor, especially to the US, as almost 8 of the 24 promising vaccines approved for clinical trials are from China. It used the technology of ‘inactivated vaccine’ which basically means killing the actual virus and using that to create a vaccine. This method is quite useful in treating measles and influenza, thus, increasing the chances of success in the case of COVID-19 as well.

“It’s a tried and true strategy”, Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, said  about the inactivated vaccine. One potential vaccine from China-based Sinopharm is already in the phase 3 of trials whereas Sinovac will enter the third phase this month. Moreover, China has permitted Sinovac and Sinopharm to dilute phase 1 and 2 of vaccine trials on humans to hasten the process.

The head of the Chinese Center for Disease Control and Prevention, Gao Fu, had also been injected with a potential vaccine on July 28, 2020. “I’m going to reveal something undercover: I am injected with one of the vaccines'' Gao Fu said in a webinar hosted by Alibaba Health, an arm of the Chinese e-commerce giant, and Cell Press, an American publisher of scientific journals. However, he did not reveal any more details about how and when exactly he administered himself with the vaccine and ‘hopes’ that the vaccine works.

Vladimir Putin, President of Russia | Source: Wikimedia

Elsewhere in Russia, on August 11, 2020, President Vladimir Putin proudly announced that Russia was the first country to grant regulatory approval to their vaccine after carrying out human trials for less than 2 months by the Gamalei Institute in Moscow. Regulatory approval permits vaccination of the masses. Although it has not undergone phase 3 of trials, Russia expects to initiate mass production of the vaccine by the end of this year. Kirill Dmitriev, head of Russia's sovereign wealth fund states that the vaccine will be called ‘Sputnik V’, named after Sputnik 1, the first satellite launched by Soveit Union which was a euphoric moment for Russia. More recently, China and Russia have joined hands in proceeding with the clinical trials of their vaccines.

These two instances seem to bring a new hope for the future, yet raise alarms and invite scepticism from the experts in the field of public health. One major concern is that without prolonged trials, vaccines should not be authorized for public use. Anthony Fauci, an infectious disease expert based in the US said “I do hope the Chinese and the Russians are actually testing the vaccines before they are administering the vaccine to anyone. Because claims of having a vaccine ready to distribute before you do testing is problematic at the very least”. Hence, some people are still in doubt regarding the safety of the product. Putin, however, rubbished such concerns and said "I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks".

An Indian biotechnological company, Bharat Biotech developed ‘Covaxin’ in collaboration with Indian Council for Medical Research (ICMR), using the mechanism of inactivated vaccine. It was successful in getting approval for human trials which were scheduled to begin in July, 2020. Initial reports stated that it would be ready for mass use by August 15, 2020, which also marked the 73rd Independence Day of India. However, Bharat biotech was clear in letting the public know that phase 1 of the trials are still on-going. ICMR cleared the confusion by stating that it would prepare the results of the phase 1 trials by August 15, 2020, not the actual vaccine for use. Phase 2 of the trials are awaited in September, 2020.

So far, the results of phase 1 trials have been positive as no serious side-effects are observed in the vaccine candidates. “The vaccine has been safe. No adverse effect has been reported. Even the point of injection pain, which is normal in vaccines, has been very mild” said Dr Kushwaha of Prakhar Hospital.

Meanwhile, the South Korean government stated on August 21, 2020, that it will secure adequate vaccine supply to its citizens by cooperating with international bodies and promoting local drug development. Three South Korean companies have started the process of making a vaccine and all are in the clinical trial phase. Bill Gates asserts that the South Korean pharmaceutical company, SK Bioscience, will have around 200 million vaccine doses ready by June 2021.

Japan is jointly collaborating with the UK, France and other European countries to establish a $20 billion fund to buy coronavirus vaccines, with Japan pledging a contribution of $800 million. It’s vaccine program aims to focus on giving primary attention to its medical workers and the elderly people of the country when the first doses of the vaccine are made. The state-funded vaccination program is believed to be officially adopted by Japan in September this year with negotiations with the UK and US based drug makers already in place.

With the race to bring COVID-19 vaccine seemingly coming to a close and it will hopefully be ready by the end of 2020 or early 2021. Till then, the entire world is watching this race with bated breath.

Read More